Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
- Where
- Charlotte, Winston-Salem
- Age
- 18 years to 64 years
- People
- 120
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06945042 - Phase 2Taking peopleCombination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 20
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07046078 - Phase 1Taking peopleA Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
- Where
- Duarte, Sacramento, San Diego
- Age
- 18 years and over
- People
- 28
- Run by
- Aspera Biomedicines, Inc.
See details and how to joinNCT07250646 - Phase 2Taking peopleCladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
- Where
- Houston
- Age
- 60 years and over
- People
- 160
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01515527 - Phase 1Taking peopleTagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
- Where
- Duarte
- Age
- 18 years to 75 years
- People
- 43
- Run by
- City of Hope Medical Center
See details and how to joinNCT06498973 - Phase 1Taking peoplePemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia
- Where
- Dallas, Portland
- Age
- 18 years and over
- People
- 32
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT04659616 - Phase 1Taking peopleHM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 45
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT06594445 - Phase 2Taking peopleTagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
- Where
- Buffalo, Chapel Hill, Miami, Orlando, Philadelphia, Providence, Winston-Salem
- Age
- 18 years and over
- People
- 53
- Run by
- Joshua Zeidner
See details and how to joinNCT05442216 - Phase 1Taking peopleCD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 16
- Run by
- University of Pennsylvania
See details and how to joinNCT05945849 - No phaseTaking peopleCD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- Up to 25 years
- People
- 50
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT03810196 - Phase 2Taking peopleTrial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Where
- Hackensack, Los Angeles, Nashville, New York, Portland, Tampa
- Age
- 18 years and over
- People
- 80
- Run by
- Orca Biosystems, Inc.
See details and how to joinNCT07216443 - Phase 1Taking peopleCART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Philadelphia
- Age
- 0 years to 29 years
- People
- 30
- Run by
- Stephan Grupp MD PhD
See details and how to joinNCT07464951 - No phaseTaking peopleA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Where
- Akron, Amarillo, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Beech Grove, Bethesda, Birmingham, Boston, Brandywine, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Fort Sam Houston, Fort Worth, Gainesville, Gilbert, Glendale, Grand Rapids, Hackensack, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, La Jolla, Lake Sucess, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madison, Maywood, Memphis, Miami, Milwaukee, Morgantown, Nashville, New Brunswick, New Haven, New Hyde, New Orleans, New York, Oakland, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Stanford, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem, Worcester, Zion
- People
- 99,999
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01351545 - Phase 2Taking peopleAllo HSCT Using RIC and PTCy for Hematological Diseases
- Where
- Minneapolis
- Age
- Up to 75 years
- People
- 56
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605 - No phaseTaking peopleA Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- Where
- Birmingham, Chapel Hill, Rochester, Winston-Salem
- Age
- 60 years and over
- People
- 1,020
- Run by
- University of Rochester
See details and how to joinNCT06697600 - No phaseTaking peopleCaris Chromoseq Data Collection
- Where
- Phoenix
- Age
- 18 years and over
- People
- 300
- Run by
- Caris Science, Inc.
See details and how to joinNCT07680868 - Phase 2Taking peopleCLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- Where
- Baltimore
- Age
- 18 years and over
- People
- 39
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT04050280 - Phase 1Taking peopleIntravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
- Where
- Rochester, Scottsdale
- Age
- 18 years and over
- People
- 21
- Run by
- Mayo Clinic
See details and how to joinNCT06508463 - No phaseTaking peopleHalt Aging in Survivors of Blood Cancers
- Where
- Omaha
- Age
- 50 years and over
- People
- 180
- Run by
- University of Nebraska
See details and how to joinNCT07292272 - Phase 1Taking peopleIadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia
- Where
- Portland
- Age
- 18 years and over
- People
- 30
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT06357182 - No phaseTaking peopleClonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Where
- Boston
- Age
- 18 years and over
- People
- 5,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07675967 - No phaseTaking peopleRegistry of Older Patients With Cancer
- Where
- Boone, Chapel Hill, Greenville, Hendersonville, Morehead City, New Bern, Raleigh
- Age
- 65 years and over
- People
- 3,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137825 - Phase 2Taking peopleVedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- Where
- Duarte
- Age
- 18 years to 80 years
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT06815003 - Phase 2Taking peopleIntensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
- Where
- Chicago
- Age
- 18 years to 65 years
- People
- 38
- Run by
- University of Illinois Chicago
See details and how to joinNCT06802315 - Phase 2Taking peopleMyeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
- Where
- Minneapolis
- Age
- Up to 60 years
- People
- 300
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03314974